Rolapitant—a new and safer antiemetic agent
نویسندگان
چکیده
منابع مشابه
New antiemetic drugs.
BACKGROUND Important progress in the prophylaxis of chemotherapy-induced acute and delayed emesis has been achieved but some fundamental needs still remain that requires new, efficacious antiemetic drugs. METHODS A critical review of the results of published studies of aprepitant, a new NK1 receptor antagonist, and of palonosetron, a 5-HT3 receptor antagonist with a longer half-life. RESULT...
متن کاملNew Impossible Differential Attack on SAFER + and SAFER + +
SAFER+ was a candidate block cipher for AES with 128-bit block size and a variable key sizes of 128, 192 or 256 bits. Bluetooth uses customized versions of SAFER+ for security. The numbers of rounds for SAFER+ with key sizes of 128, 192 and 256 are 8, 12 and 16, respectively. SAFER++, a variant of SAFER+, was among the cryptographic primitives selected for the second phase of the NESSIE project...
متن کاملA new class of antiemetic agents on the horizon.
This article reviews a new class of antiemetic agents, the neurokinin-1 (NK-1) receptor antagonists (RAs). Clinical trials of an NK-1 RA, aprepitant, are ongoing.
متن کاملThe SAFER Matrix: A New Scoring Methodology.
A New Scoring Methodology Project REFRESH (see related articles on pages 3 and 5), the Joint Commission’s multiphase process improvement project, includes a transformative approach for identifying and communicating risk levels associated with deficiencies cited during surveys. This Survey Analysis for Evaluating Risk (SAFER) approach provides organizations with additional information related to...
متن کاملSometimes new does not mean safer
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, pleas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Reviews Clinical Oncology
سال: 2015
ISSN: 1759-4774,1759-4782
DOI: 10.1038/nrclinonc.2015.144